UVEAL MELANOMA, METASTATIC
Clinical trials for UVEAL MELANOMA, METASTATIC explained in plain language.
Never miss a new study
Get alerted when new UVEAL MELANOMA, METASTATIC trials appear
Sign up with your email to follow new studies for UVEAL MELANOMA, METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer drug MBS8(1V270) enters first human trials
Disease control Recruiting nowThis early-stage trial is testing an experimental drug called MBS8(1V270), given alone or with the immunotherapy pembrolizumab, in people with advanced solid tumors that have not responded to standard treatments. The main goals are to check safety and find the right dose. About 1…
Matched conditions: UVEAL MELANOMA, METASTATIC
Phase: PHASE1 • Sponsor: MonTa Biosciences ApS • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
New combo therapy aims to boost immune attack on eye cancer
Disease control Recruiting nowThis early-stage trial tests whether adding a new drug called roginolisib to the existing treatment tebentafusp can help people with advanced uveal melanoma, a rare eye cancer. The study involves 8 adults whose cancer has spread and who are already on tebentafusp. The main goal i…
Matched conditions: UVEAL MELANOMA, METASTATIC
Phase: PHASE1 • Sponsor: St Vincent's Hospital, Sydney • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Radioactive drug targets Hard-to-Treat melanoma in early trial
Disease control Recruiting nowThis early-stage trial tests a radioactive drug called [225Ac]Ac-A9-3408 in 50 adults with melanoma that has spread or can't be removed by surgery. The main goals are to find a safe dose and check for side effects. Participants receive the drug every 6 weeks for up to 6 doses, an…
Matched conditions: UVEAL MELANOMA, METASTATIC
Phase: PHASE1 • Sponsor: Alpha-9 Oncology USA Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New capsule aims to fight rare eye cancer that spreads
Disease control Recruiting nowThis study tests an experimental drug called NBM-BMX in people with metastatic uveal melanoma, a rare eye cancer that has spread to other parts of the body. The goal is to find the best dose, check for side effects, and see if the drug can shrink or slow tumors. Participants take…
Matched conditions: UVEAL MELANOMA, METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: Novelwise Pharmaceutical Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC